For now, the idea of editing embryos to treat diseases is futuristic, and no scientists have proposed to do such work. The procedure is simply not safe enough to use in clinics yet. One major concern is that changes to an embryo’s DNA could have unknown harmful consequences throughout a person’s body. Worse, that genetic damage would be passed on for generations to come, through the affected person’s sperm or eggs. Another concern is the prospect of designer babies, where a child’s DNA is modified to suit their parents’ wishes.
Earlier this month, leading UK funders called for a national debate on whether editing human embryos could ever be justified in the clinic. Weeks later, international experts belonging to the Hinxton Group said it did not yet approve of GM babies being born, but added that “when all safety, efficacy and governance needs are met, there may be morally acceptable uses of this technology in human reproduction.”
Robin Lovell-Badge, head of stem cell biology at the Francis Crick Institute and a member of the Hinxton Group, said: “There is clearly lots of interesting and important research you can do with these techniques which has nothing to do with clinical applications.” But, he added: “We are absolutely not ready for clinical applications yet.”
Be the first to like.
The Guardian